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Abstract In this research study, the formation and charac-
terization of new ruthenium(II) and (III) complexes encom-
passing multidentate ligands derived from 6-acetyl-1,3,
7-trimethyllumazine (almz) are reported. The 1:1 molar coor-
dination reactions of trans-[RuCl2(PPh3)3] with N-1-[1,3,
7-trimethyllumazine]benzohydride (bzlmz) and 6-(N-methy-
loxime)-1,3,7-trimethyllumazine (ohlmz) formed a diamag-
netic ruthenium(II) complex, cis-[RuCl2(bzlmz)(PPh3)] (1),
and paramagnetic complex, cis-[RuIIICl2(olmz)(PPh3)] (2)
[Holmz = 6-(N-hydroxy-N0-methylamino)-1,3,7-trimethyl-
lumazine], respectively. These ruthenium complexes were
characterized via physico-chemical and spectroscopic
methods. Structural elucidations of the metal complexes
were confirmed using single crystal X-ray analysis. The
redox properties of the metal complexes were investigated
via cyclic voltammetry. Electron spin resonance spec-
troscopy confirmed the presence of a paramagnetic metal
centre in 2. The radical scavenging activities of the metal
complexes were explored towards the DPPH and NO radi-
cals. Quantum calculations at the density functional theory
level provided insight into the interpretation of the IR and
UV–Vis experimental spectra of 1.
Introduction
The exploration of ruthenium in medicinal inorganic
chemistry is largely due to the discovery of NAMI A, trans-
[RuCl4(DMSO)(Im)](ImH) {ImH = protonated imidazole}
and KP1019 (trans-tetrachlorobis(indazole)ruthenate(III))
as potential metal-based anticancer drugs [1, 2]. Their high
cytotoxicity towards metastatic tumours is accounted to the
fact that ruthenium is a group congener of the essential ele-
ment, iron, and these first-generation ruthenium
chemotherapeutic drugs share similar biodistribution pat-
terns as iron [3, 4]. However, more innovative drug design
strategies are required to negate the common side effects
associated with chemotherapy [5].
A current design strategy entails the use of scaffolds
encompassing biologically significant moieties within the
coordination sphere of ruthenium complexes [6]. These
biologically significant moieties may promote the physio-
logical biocompatibility of the ruthenium complex and can
also facilitate a target-specific biodistribution towards
tumours [7]. Hence, the design of new target-specific
ruthenium chemotherapeutic drugs provides scope for
exploring the fundamental coordination chemistry of
ruthenium towards biologically relevant ligand systems.
A plausible candidate as a biologically active moiety is
lumazine which is a derivative of the enzyme, Lumazine
synthase [8]. Lumazine synthase plays a pivotal role in the
body through catalysing the formation of riboflavin (vita-
min B2) [9]. Deficiency of riboflavin has been found to be
associated with high tendencies of breast and cervical
cancer occurrences [10]. Moreover, one of the annealed
ring systems of lumazine is a uracil which is a constituent
of well-established chemotherapeutic drugs, uramustine
and 5-fluoro-uracil [11]. In fact, the coordination suscep-
tibility of Schiff bases derived from 5, 6-diamino-1,
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3-dimethyluracil towards ruthenium has been demonstrated
[12, 13].
Herein, the isolation of new ruthenium complexes con-
taining ligands derived from 6-acetyl-1,3,7-trimethyl-
lumazine (almz) is reported. The coordination reactions
using trans-[RuCl2(PPh3)3] as the metal precursor
yielded the diamagnetic ruthenium(II) complex,
cis-[RuCl2(bzlmz)(PPh3)] (1), and paramagnetic ruthe-
nium(III) complex, cis-[RuCl2(olmz)(PPh3)] (2). The
resultant metal complexes were spectroscopically charac-
terized and structurally elucidated with single-crystal X-ray
analysis. In addition, the potential antioxidant capabilities
of these metal complexes were evaluated by means of
radical scavenging studies with DPPH and NO radicals.
Experimental
Materials and methods
Trans-[RuCl2(PPh3)3], 6-amino-1,3-dimethyl-5-nitrosouracil,
acetylacetone, benzhydrazide, hydroxylamine hydrochloride,
2,2-di(4-tert-octylphenyl)-1-picrylhydrazyl (DPPH), Griess
reagent, sodiumnitroprusside, phosphate-buffered saline (PBS)
tablets and electrochemical-analysis-grade tetrabutylammo-
niumhexafluorophosphatewere obtained fromSigma-Aldrich.
All solvents and common salts were obtained fromMerck SA.
Reagent-grade toluene was dried over sodium wire while the
other solvents and the other chemicals were used without any
further purification.Ultrapurewaterwasproduced fromanElga
Purelab Ultra system. The pro-ligand, 6-acetyl-1,3,7-
trimethyllumazine (almz) was obtained from the reaction of
6-amino-1,3-dimethyl-5-nitrosouracil with acetylacetone [14].
The synthetic procedures and characterization data for the free
ligands (viz. bzlmz and ohlmz) can be found in the online
supporting information document (figures S1–S4). The syn-
thetic procedure for bzlmz was adopted and modified from a
method previously reported [15]. The free ligand, ohlmz, was
isolated from an experimental procedure attained from the lit-
erature [16].
The infrared spectra were recorded on a PerkinElmer
Spectrum 100 in the 4000–350 cm-1 range. The 1H nuclear
magnetic resonance and 31P spectra were obtained using a
Bruker Avance 400 MHz spectrometer. All NMR spectra
were recorded in deuterated dimethylsulphoxide.
UV–Vis spectra were recorded using a PerkinElmer
Lambda 25. The extinction coefficients (e) are given in
dm3 mol-1 cm-1. Melting points were determined using a
Stuart SMP3 melting point apparatus. The conductivity
measurements were determined at 295 K on a Radiometer
R21M127 CDM 230 conductivity and pH meter. Elemental
analysis (EA) was carried out using a CHNS-O Flash 2000
Organic Elemental Analyser. Mass spectrometry (MS) was
conducted in both the positive and negative modes via
direct injection of the samples into a Waters Micromass
LCT Premier MS instrument equipped with an electrospray
ionization (ESI) source and a time-of-flight (TOF) mass
analyser.
Voltammetric measurements were done using an
Autolab potentiostat equipped with a three electrode
system: a glassy carbon working electrode (GCWE), a
pseudo Ag|AgCl reference electrode and an auxiliary Pt
counter electrode. The Autolab Nova 1.7 software was
utilized for the operation of the potentiostat and data
analysis. The ruthenium metal complexes were made up
in 2 mM solutions in CH2Cl2 along with tetrabutylam-
monium hexafluorophosphate (0.1 M) as a supporting
electrolyte. Between each measurement, the GCWE
electrode surface was polished with a slurry of ultrapure
water and alumina on a Buehler felt pad followed by
rinsing with excess ultrapure water as well as ultra-soni-
cation in absolute ethanol.
The experimental procedures of the radical scavenging
studies were adapted from the literature methods [17, 18].
All experiments were run in triplicate, and the percentage
radical scavenging activities were determined via the fol-
lowing equation:
%Radical scavenging activity ¼ Ac  Afð Þ=Ac½   100
where Ac is the absorbance of the control (DPPH or NO
radicals) and Af is the absorbance upon addition of the
ligand or metallic compound to the control. In turn, the
IC50 values of the respective ligands and their metallic
compounds were calculated from the percentage radical
scavenging activity. Each IC50 value has a standard devi-
ation less than 3 % with respect to its mean value. Firstly,
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the UV–Vis spectrum of the control [0.2 mM solution of
DPPH in dichloromethane (DCM)] was measured, and
thereafter 0.1 cm3 of the metallic compound or the free
ligand (30 lM in DCM) was added. The resultant solutions
were shaken vigorously and left to stand for 20 min in the
dark, and then their respective UV–Vis spectra were
measured. The vitamin C analysis was done in a similar
manner with the exception that both the vitamin C solution
and its DPPH control solution were prepared in methanol.
The NO radical assay was done using the following
experimental procedure: a 5 mM solution of sodium
nitroprusside was prepared in phosphate-buffered saline
solution. The Griess reagent (0.5 cm3) was added to
0.3 cm3 of the nitroprusside solution. The UV–Vis spec-
trum of the mixture was taken which constitutes the con-
trol. The sample solutions were prepared by adding 1 cm3
of the metal complex, vitamin C or the free ligand (30 lM
in DMSO) to a 0.3 cm3 volume of sodium nitroprusside
solution, and the resultant mixture was allowed to incubate
for 3 h at room temperature. After the incubation period,
0.5 cm3 of the Griess reagent was added, which was fol-
lowed by measurement of the respective UV–Vis spectra.
Preparation of cis-[RuCl2(bzlmz)(PPh3)] (1)
A mixture of bzlmz (0.04 g; 0.10 mmol) and trans-
[RuCl2(PPh3)3] (0.10 g; 0.10 mmol) was dissolved in
20 ml of toluene. The resultant solution was heated until
reflux for 6 h and filtered. Slow evaporation of the mother
liquor gave dark brown crystals suitable for X-ray analysis.
Yield = 0.06 g (68 %); M.P = 280–282 C; IR (mmax/
cm-1): m(N–H)amide 3374 (w), t(C=O)lumazine 1710, 1692
(s), t(C=O)amide 1623 (s), t(C=N)lumazine 1534 (s),
m(C–N)amide 1268 (m), m(Ru-PPh3) 695 (vs);
1H NMR
(295 K/ppm): 11.0 (s, 1H, N6), 9.36 (s, toluene), 8.2
(d, 2H, H14, H18), 7.7–7.1 (m, 18H, H15, H16, H17,
PPh3), 3.6 (s, 3H, C8–H3), 2.7 (d, 6H, N1–CH3, N2–CH3),
2.1 (s, 3H, C11–H3);
31P NMR (295 K/ppm): 25.6; UV–
Vis (DCM, [kmax (e, M
-1 cm-1)]): 300 nm (19139),
366 nm (10931), 447 nm (7392), 677 nm (474); Conduc-
tivity (DCM, 10-3 M): 9.2 O-1 cm-2 mol-1; Anal. Calc.
for C43H40Cl2N6O3PRu (%): C, 57.9; H, 4.5; N, 9.4.
Found: C, 58.0; H, 4.2; N, 9.0; TOF–MS (m/z): Calcd:
909.1 [M]; Found: 799.1 [M-H2O–C7H8].
Preparation of cis-[RuCl2(olmz)(PPh3)] (2)
The title compound was formed from the 1:1 molar ratio
reaction of ohlmz (0.03 g; 0.10 mmol) with trans-
[RuCl2(PPh3)3] (0.10 g, 0.10 mmol) in 20 ml of toluene
after 6 h of heating at reflux temperature. A maroon pre-
cipitate was filtered off and recrystallized by the slow
diffusion of dichloromethane into n-hexane [1:1 (v:v)],
which resulted in the formation of brown XRD quality
crystals. Yield = 0.04 g (63 %); M.P[ 350 C; IR (mmax/
cm-1): m(C=O) 1688, 1620 (vs), m(C=N) 1559 (m), m(Ru–
PPh3) 696 (s); UV–Vis (DCM, [kmax (e, M
-1 cm-1)]):
350 nm (6502), 461 nm (6646), 707 nm (550); Conduc-
tivity (DCM, 10-3 M): 15.0 O-1 cm-2 mol-1; Anal. Calc.
for C28H27Cl2N5O3PRu (%): C, 49.1; H, 4.0; N, 10.2.
Found: C, 49.1; H, 4.0; N, 9.9; TOF–MS (m/z): Calcd:
684.0 [M]; Found: 684.0 [M].
X-ray diffraction
The X-ray data for the metal complexes were recorded on a
Bruker Apex Duo equipped with an Oxford Instruments
Cryojet and an Incoatec microsource operating at 30 W
power. Crystal and structure refinement data for 1 are given
in Table 1. The bond lengths and angles for 1 are given in
Table 2 for 1. C7H8H2O. Only a low-resolution structure
could be obtained for 2 (figure S3). In both cases, the data
were collected with Mo Ka (k = 0.71073 A˚) radiation at a
crystal-to-detector distance of 50 mm. The following
conditions were used for data collection: omega and phi
scans with exposures taken at 30 W X-ray power and 0.50
Table 1 Crystal data and structure refinement data
1 H2OC7H8
Chemical formula C43H43Cl2N6O4PRu
Formula weight 910.77
Temperature (K) 100(2)
Crystal system Triclinic
Space group P-1
Unit cell dimensions (A˚
´
, ) a = 10.162(5)
b = 13.587(5)
c = 16.268(5)
a = 105.202(5)
b = 106.096(5)
c = 103.762(5)
Crystal size (mm) 0.19 9 0.18 9 0.12 mm
V (A˚3) 1962.2 (13)
Z 2
Density (calc.) (Mg/m3) 1.541
Absorption coefficient (mm-1) 0.629
F(000) 936
h range for data collection () 1.39; 26.05
Reflections measured 31830
Observed reflections [I[ 2r(I)] 7117
Independent reflections 7653
Data/restraints/parameters 7653/1/527
Goodness of fit on F2 1.078
Observed R, wR2 0.0336; 0.0824
Rint 0.026
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frame widths using APEX2 [19]. The data were reduced
with the program SAINT [19] using outlier rejection, scan
speed scaling, as well as standard Lorentz and polariza-
tion correction factors. A SADABS semi-empirical multi-
scan absorption correction [20] was applied to the data.
Direct methods, SHELX-2014 [21] and WinGX [22] were
used to solve both structures. All non-hydrogen atoms
were located in the difference density map and refined
anisotropically with SHELX-2014 [21]. All hydrogen
atoms were included as idealised contributors in the least
squares process. Their positions were calculated using a
standard riding model with C–Haromatic distances of 0.93
A˚ and Uiso = 1.2 Ueq, C–Hmethylene distances of 0.99 A˚
and Uiso = 1.2 Ueq and C–Hmethyl distances of 0.98 A˚ and
Uiso = 1.5 Ueq. The hydrogen atoms of the water mole-
cule and the amino NH of 1 were located in the difference
density map and refined isotropically. The O1w–H2w
bond distance was restrained using a DFIX command with
a distance of 087 A˚ and ESD = 0.02. Disordered solvent
in the lattice of compound 2 was removed using the
Platon SQUEEZE routine [23]. This left solvent accessi-
ble voids of 566 A˚3.
Computational details
Quantum calculations were conducted with GAUSSIAN
09 W [24]. Geometry optimization of the ruthenium
complex 1 was achieved through a DFT calculation using
the B3LYP functional, with an accompanying hybrid basis
set viz. the 6-311G?? (d, p) basis set was applied to all the
C, H, N, O, Cl and P atoms and the LANL2DZ basis set,
which makes use of effective core potentials, applied to the
metal centre [25]. Prior to the calculation, the solvent
molecules of recrystallization for 1 were omitted from the
crystal structure, and the resultant structure was used as the
starting conformer. Good agreement was found between
the optimized and geometrical parameters (refer to
Table 2) with the minor deviations attributed to the fact
that gas-phase-optimized structures do not account for non-
classical hydrogen bonding interactions or any short dis-
tance contacts. Using the optimized structure of the metal
complex, the lack of any negative eigenvalues in the fre-
quency calculations confirmed that the structure is at a
global minimum on the potential energy surface [26].
Results and discussion
Synthesis, spectral characterization
and computational studies
The ruthenium(II) and (III) complexes 1 and 2 were for-
mulated from the 1:1 molar coordination reactions between
trans-[RuCl2(PPh3)3] and their respective free ligands,
bzlmz and ohlmz, respectively. In 1 and 2, the bzlmz and
olmz chelators coordinate via their respective tridentate
NiminoNpyrazineOketonic and OketonicNpyrazineOnitroso donor
sets (Figs. 1 and S3). Interestingly, a fascinating transfor-
mation is observed from the free ligand, ohlmz to the olmz
chelator, refer scheme S1.
The IR spectra of bzlmz and its complex (figure S4)
show numerous vibrations between 1200 and 1800 cm-1
which are poorly resolved due to the extended p-conjuga-
tion within bzlmz. However, frequency calculations aided
in the interpretation of these vibrations (figure S5). More
specifically, the simulated spectrum of 1 indicated a dis-
tinctive difference between coordinated and uncoordinated
ketonic vibrations at 1669 and 1776 cm-1, respectively. In
the overlay IR spectra of 1 and its free ligand, the lumazine
ketonic stretches appear as an intense broad vibrational
band at 1694 cm-1 (for the free ligand, bzlmz), which
splits into two vibrational bands at 1692 cm-1 (coordi-
nated) and 1710 cm-1 (uncoordinated) in 1.
The m(C=O)amide is observed at 1740 cm
-1 in the sim-
ulated spectrum of 1 while in the experimental spectra of 1
and its free ligand, the amide C=O vibrations [1623 cm-1
for 1 and 1652 cm-1 for bzlmz free ligand] are found
below the ketonic lumazine vibrations. The simulated
amide C–N (1265 cm-1) and C=N (1561 cm-1) stretches
compare well with the corresponding wavenumbers found
for the peak in the experimental spectra of 1 [m(C=N) at
1534 cm-1 and m(C–N) at 1268 cm-1] and its free ligand
[m(C=N) at 1547 cm-1 and m(C–N) at 1268 cm-1]. For 1,
the N–H bond vibrates essentially at the same positions at
3374 and 3377 cm-1 in the experimental and simulated IR
spectra, respectively. In both the experimental IR spectra of
1 and 2, an intense characteristic ruthenium to triph-
enylphosphine signal is observed as 695 and 696 cm-1,
respectively (figure S6) [27].
Table 2 Selected bond lengths [A˚] and bond angles [] for 1
Experimental Optimized
Ru–P 2.333(8) 2.4066
Ru–N4 1.903(2) 1.9525
Ru–N5 2.003(3) 2.0056
Ru–Cl1 2.412(1) 2.4821
Ru–Cl2 2.4527(9) 2.4481
C12–O3 1.222(3) 1.2175
C2–O1 1.248(4) 1.2357
C4–O2 1.210(4) 1.2109
N5–Ru–N4 77.47(9) 78.291
N4–Ru–O1 78.47(8) 78.887
N5–Ru–O1 155.84(8) 153.174
Cl1–Ru–N4 173.42(7) 171.196
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The 1H NMR spectrum of 1 is dominated by an intense
multiplet attributed to the signals of the triphenylphosphine
co-ligand and selected phenylic protons of the bzlmz
chelator (figure S7). The remaining aromatic signal res-
onates as a doublet at 8.2 ppm. The amide and methyl
signals of the bzlmz chelator in 1 are found essentially at
the same positions to analogous signals found within the
proton spectrum of the corresponding free ligand, bzlmz.
As expected, only one signal is observed in the 31P NMR
spectrum of 1 for its triphenylphosphine co-ligand
(figure S8).
The UV–Vis spectra of the metal complexes both show
intense p–p* intraligand transitions below 400 nm associ-
ated with the conjugated bzlmz (in 1) and olmz (in 2)
chelators (figure S9 and S10). At more redshifted regions
(between 400 nm and 600 nm), distinctive charge transfer
bands appear; a metal-to ligand charge transfer band at
477 nm and ligand-to-metal charge transfer band at
461 nm for 1 and 2, respectively. Despite complex 1
having a low-spin d6 electron configuration, it also has a
metal-based d–d electronic transition such as observed for
the paramagnetic complex 2 [677 nm for 1 and 707 nm for
2]. The presence of the metal-based electronic transition of
1 is ascribed to a low-band-gap energy (2.685 eV) which
makes the d–d electronic transition favourable. This finding
concurs with our previous report where comparable band
gap energies were attained for the optimized structures of
the ruthenium(II) complex cation, [RuCl(Hobz)2(PPh3)]
?
(Hobz = 2-hydroxyphenylbenzimidazole) [band-gap ener-
gy = 3.189 eV] and the paramagnetic ruthenium complex,
[RuIIICl(obs)2(PPh3)] [band-gap energy = 3.236 eV]; this
computational data explained why both these metallic
compounds had distinctive d–d electronic transitions [28].
The EPR spectrum of 2 (figure S11) was obtained only
in the solid-state at room temperature. A low resolution
singlet (g value = 2.01) confirmed the presence of the
paramagnetic metal centre of complex 2 in the solid-state
at 298 K. The nature of the EPR spectrum of 2 is charac-
teristic of some low spin ruthenium(III) octahedral com-
plexes [29]. The EA data compare well with the calculated
exact masses of the respective metal complexes while the
low resolution mass spectra of 1 and 2 showed peaks
corresponding to [M-H2O–C7H8] at m/z 799.1 and [M] at
m/z 684.0 (figures S12 and S13).
Electrochemistry studies
The CVs of 1 and 2 showed single redox couples attributed
to the Ru(II)/Ru(III) redox couples as seen in figure S14.
The assignment is made based on the fact that their half-
wave potentials [E = 0.96 V (for 1) and 0.83 V (for 2)
vs. Ag|AgCl] reside in the potential window of -0.15 and
0.96 V for halfwave potentials attained for mononuclear
diamagnetic and paramagnetic ruthenium complexes under
Fig. 1 An ORTEP view of compound 1 showing 50 % probability displacement ellipsoids and the atom labelling. The hydrogen atoms and
toluene molecule of crystallization were omitted for clarity
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similar electrochemical conditions [28, 30]. In addition,
these redox couples correspond to one-electron redox
processes governed by their peak to peak separations (Ipa/
Ipc) approaching 1. Furthermore, the redox couples are
quasi-reversible as the peak-to-peak separations of 1
(DE = 80 mV) and 2 (DE = 70 mV) are smaller than that
of the standard ferrocene (90 mV at 100 mV/s), indicating
faster electron transfer kinetics for the metal complexes.
Also, the two redox couples displayed diffusion-controlled
behaviour with increasing scan rates. For instance, fig-
ure S15 shows overlay CVs of complex 2 for scan rates
ranging from 25 to 200 mV/s, at increments of 25 mV/s.
Radical scavenging studies
The mutation of healthy cells by free radicals is reported to
be a common cause of cancer, Alzheimer’s disease and
cardiovascular diseases [31, 32]. To deter the negative
effects of these free radicals, more effective radical scav-
engers are required other than the natural antioxidant,
vitamin C. Previous studies have illustrated that ruthenium
compounds can be effective radical scavengers, largely
owing to their optimal redox properties [33]. Indicative of
these previous studies, the formulated ruthenium com-
pounds 1 and 2 with lumazine moieties are found to have
significantly higher DPPH [IC50(DPPH) = 46 lM (for 1)
and 63 lM (for 2)] and NO [IC50(NO) = 36 lM (for 1)
and 34 lM (for 2)] radical scavenging activities in com-
parison with vitamin C [IC50(NO) = 210 lM and IC50
(DPPH) = 147 lM] [33–35]. Furthermore, the metallic
compounds have lower IC50 values than their correspond-
ing ligands [IC50(DPPH) = 392 lM (for bzlmz) and
109 lM (for ohlmz); IC50(NO) = 1002 lM (for bzlmz)
and 125 lM (for ohlmz)] which emphasizes the influence
of the metal atoms in 1 and 2.
In fact, the influence of the bzlmz chelator on the radical
scavenging capability of 1 can be regarded as negligible.
This deduction is based on the high IC50 values of the free
ligand, bzlmz, when used for the scavenging of the DPPH
and NO radicals, respectively. In contrast to metal-centred
radical scavenging activity of 1, the IC50 values of the free
ligand, ohlmz, suggested that there could be a synergistic
mechanistic effect of radical activity induced by the redox
activity of the metal centre and the donation of hydrogen
by the olmz chelator of 2.
Crystallographic studies
Complex 1 co-crystallizes with a water and a toluene
molecule of recrystallization within its crystal lattice
(Fig. 1). Molecules of 1 afford chains parallel to the
[a]-axis induced by hydrogen bonding between the
water molecule and adjacent molecules of 1
[O4–HBN3 = 2.15(7) A˚ and O4–HACl2 = 2.22(5) A˚,
N6–H44O4 = 2.02(4) A˚] (figure S16). The crystal lattice
of 1 is further stabilized by classical pi–pi interactions
between the C19–C24 phenyl ring (of the triphenylphos-
phine co-ligand) and the C7C9N4C1C6N3 ring (of the
bzlmz chelator) defined by the centroid-to-centroid dis-
tance of 3.370(3) A˚. Intermolecular interactions are also
observed between the nearly co-planar toluene molecule
and C6C1C2N1C4N2 ring (of the bzlmz chelator) with an
interplanar spacing of 3.771(3) A˚ (figure S17). The afore-
mentioned intermolecular interactions induced the mole-
cules of 1 to stack in columns aligned with the [b]-axis.
The constrained five-membered chelate rings within 1
[N5–Ru–N4 = 77.47(9) and N4–Ru–O1 = 78.47(8)]
afforded severe deviation in its octahedral geometry,
revealed by the equatorial angles [N5–Ru–
O1 = 155.84(8), Cl1–Ru–N4 = 173.42(7) for 1] all
deviating from linearity. Furthermore, the lumazine moiety
of 1 lies significantly out of the plane [by 87.3(2)] of the
C13–C18 phenyl ring which accounts to the flexibility of
the amide aliphatic group. The bond order of the C12–O3
[1.222(3) A˚] bond of 1 is confirmed based on its similar
distance in comparison with the ketonic C=O bonds within
1 [C2–O1 = 1.248(4) A˚ and C4–O2 = 1.210(4) A˚]. The
Lewis acidic character of the diamagnetic ruthenium atom
(in 1) affords a shorter Ru–P [2.333(8) A˚] than the analo-
gous bond (Ru–P = 2.3437(7) A˚) found in the paramag-
netic ruthenium complex, [RuIIICl(obs)2(PPh3)] [28]. In
addition, the difference in the cis-oriented Ru–Cl bonds of
1 [Ru–Cl1 = 2.412(1) A˚ and Ru–Cl2 = 2.4527(9) A˚] are
accounted to the variable trans-influence imposed on the
halides. The ruthenium-to-lumazine nitrogen coordination
bond length of 1 is 1.903(2) A˚.
Although no ruthenium compounds (besides 1) bearing
lumazine moieties can be found in the Cambridge Crys-
tallographic Data Centre (CCDC), several transition metal
complexes with lumazine chelates have been isolated [15,
36–40]. Among these transition metal complexes, the
lumazine moiety and its multidentate chelators exhibit
diverse coordination modes affording metal complexes
with unique molecular geometries. In addition, several of
these metal complexes exhibit unique anticancer activities
while the presence of the lumazine moiety within the
coordination sphere of various d-block metals induces
unique luminescent behaviours [37, 40].
Conclusion
Novel diamagnetic and paramagnetic ruthenium complexes
with multidentate lumazine chelates were formed and
spectroscopically characterized.Quantum calculations at the
DFT level aided in the interpretation of the experimental
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spectra of the metal complex 1. X-ray analysis affirms the
structural elucidations, indicating the metal atoms are in the
centres of distorted coordination spheres which are induced
by their respective constrained equatorial bite angles. The
formulated ruthenium compounds 1 and 2 show excellent
capabilities for scavenging the DPPH and NO radicals
judged by their significant lower IC50 values than their cor-
responding free ligands and reported IC50 values of the
natural antioxidant, vitamin C.
Supporting information
CCDC 1463919 contains the supplementary crystallo-
graphic data for this paper. These data can be obtained free
of charge from The Cambridge Crystallographic Data
Centre via www.ccdc.cam.ac.uk/data_request/cif. Supple-
mentary figures S1–S17 associated with this article can be
found in the online version.
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